<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ablation of skeletal metastases</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ablation of skeletal metastases</h1>
<div class="graphic"><div class="figure"><div class="ttl">Ablation of skeletal metastases</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="10%"></colgroup><colgroup span="2" width="20%"></colgroup><colgroup width="10%"></colgroup> <tbody> <tr> <td class="subtitle1">Author, year</td> <td class="subtitle1">Ablation type</td> <td class="subtitle1">Number of patients</td> <td class="subtitle1">Number of tumors</td> <td class="subtitle1">Median follow-up in months</td> <td class="subtitle1">Pain reduction*<br/> (number of patients achieving, mean decrease in pain intensity<sup>¶</sup>)</td> <td class="subtitle1">Opioid reduction<br/> (MEDD or % of patients using less opioids)</td> <td class="subtitle1">Number of major complications</td> </tr> <tr> <td>Callstrom M, 2006</td> <td>RFA</td> <td class="centered">62</td> <td class="centered">62</td> <td class="centered">6</td> <td>59 of 62, 7.7 to 2.4 over 24 weeks<sup>Δ</sup></td> <td>MEDD reduced from 66 to 44 mg at 214 weeks</td> <td class="centered">4</td> </tr> <tr> <td>Dupuy D, 2009</td> <td>RFA</td> <td class="centered">55</td> <td class="centered">55</td> <td class="centered">3</td> <td>NR, 14.2<sup>◊</sup></td> <td>NR</td> <td class="centered">3</td> </tr> <tr> <td>Bagla S, 2016</td> <td>RFA</td> <td class="centered">50 (spine)</td> <td class="centered">69</td> <td class="centered">NR</td> <td>24 of 34; decrease in pain intensity (numerical pain rating scale<sup>Δ</sup>) from 5.9 to 2.1 over 3 months </td> <td>NR</td> <td class="centered">NR</td> </tr> <tr> <td>Callstrom M, 2013</td> <td>Cryo</td> <td class="centered">61</td> <td class="centered">69</td> <td class="centered">6</td> <td>42 of 61, 7.1 to 1.4 over 24 weeks<sup>Δ</sup></td> <td>83%</td> <td class="centered">1</td> </tr> <tr> <td>Tomasian A, 2015<span style="font-size: 11pt; font-family: 'Calibri','sans-serif';"><sup>§</sup></span></td> <td>Cryo</td> <td class="centered">14</td> <td class="centered">31</td> <td class="centered">10</td> <td>All 14; from 8 to 3 over 12 weeks</td> <td>MEDD reduced from 360 to 80 mg per day at 12 weeks</td> <td class="centered">2</td> </tr> <tr> <td>Liberman B, 2009</td> <td>FUS</td> <td class="centered">31</td> <td class="centered">32</td> <td class="centered">3</td> <td>18 of 25, 5.9 to 1.8 over 12 weeks<sup>Δ</sup></td> <td>67%</td> <td class="centered">0</td> </tr> <tr> <td rowspan="2">Hurwitz M, 2014</td> <td>FUS</td> <td class="centered">112</td> <td class="centered" rowspan="2">NR</td> <td class="centered" rowspan="2">NR</td> <td rowspan="2"><span style="font-size: 11pt; font-family: 'Calibri','sans-serif';">72 of 112 versus 7 of 35 control<sup><span>¥</span></sup>, mean decrease in pain intensity 7.0 to 3.4 over 12 weeks (versus 6.8 to 6.1 control)</span></td> <td rowspan="2">44% at 12 weeks (versus 14% in control arm)</td> <td class="centered" rowspan="2">3</td> </tr> <tr> <td>Sham control</td> <td class="centered">35</td> </tr> </tbody></table></div><div class="graphic_footnotes">MEDD: morphine equivalent daily dose; RFA: radiofrequency ablation; NR: not reported; Cryo: cryoablation; FUS: focused ultrasound.<br/>* Clinically significant pain reduction defined variably; refer to related UpToDate topic.<br/>¶ As indicated by a mean decrease in Visual Analog Score for pain.<br/>Δ Scale of 1 to 10.<br/><font class="lozenge">◊</font> 100-point scale, mean difference in pain intensity from baseline.<br/>§ Spine lesions only. <br/>¥ Patients whose worst numerical rating scale assessment for pain decreased by at least 2 points and whose MEDD intake did not increase by more than 25% from baseline to 3 months were considered responders.</div><div id="graphicVersion">Graphic 94177 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
